53 Clomiphene Citrate for Poor Responder Women Undergoing Ivf/Icsi Treatment Cycles: Randomised Controlled Study (original) (raw)

Clomiphene Citrate plus Modified GnRH Antagonist Protocol for Women with Poor Ovarian Response Undergoing ICSI Treatment Cycles: Randomized Controlled Trial

Nevin Gad

View PDFchevron_right

Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles

Yu-Hung Lin

Human Reproduction, 2003

View PDFchevron_right

Comparison of Low-dose Human Menopausal Gonadotropins with Clomiphene Citrate for Ovarian Stimulation in Intrauterine Insemination: A Randomized Clinical Trial

Latha Chaturvedula

International Journal of Infertility & Fetal Medicine

View PDFchevron_right

Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing IVF/ICSI: a prospective randomized controlled trial

Ai Ai

Clinical endocrinology, 2017

View PDFchevron_right

Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial

Guido Ragni, Veronica Arfuso, Federica Alagna

Reproductive Biology and Endocrinology, 2012

View PDFchevron_right

Clinical management of low ovarian response to stimulation for IVF: a systematic review

Leonidas Zepiridis

Human Reproduction Update, 2003

View PDFchevron_right

Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation

Abha Maheshwari

The Cochrane database of systematic reviews, 2017

View PDFchevron_right

Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT

batool rashidi

Iranian Journal of Reproductive Medicine, 2017

View PDFchevron_right

The SUPER study: protocol for a randomised controlled trial comparing follicle-stimulating hormone and clomiphene citrate for ovarian stimulation in intrauterine insemination

Ineke Janssen

BMJ open, 2017

View PDFchevron_right

Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing IVF/ICSI

Konstantinos Dafopoulos

In Vivo

View PDFchevron_right

Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin

Nikos Vlahos

Fertility and Sterility, 2005

View PDFchevron_right

A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial

Marwan Alhalabi

Human Reproduction

View PDFchevron_right

Effect of Administration of Single Dose GnRH Agonist in Luteal Phase on Outcome of ICSI-ET Cycles in Women with Previous History of IVF/ICSI Failure: A Randomized Controlled Trial

Mahmood Jeddi-tehrani

Journal of reproduction & infertility

View PDFchevron_right

Minimum ovarian stimulation involving combined clomiphene citrate and estradiol treatment for in vitro fertilization of Bologna-criteria poor ovarian responders

Satoru Takeda

The journal of obstetrics and gynaecology research, 2016

View PDFchevron_right

Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes

Claudio Benadiva

Fertility and Sterility, 2009

View PDFchevron_right

When is clomiphene or gonadotropin intrauterine insemination futile? Results of the Fast Track and Standard Treatment Trial and the Forty and Over Treatment Trial, two prospective randomized controlled trials

Marlene Goldman

Fertility and sterility, 2014

View PDFchevron_right

Session 31: Ovarian Stimulation 1

D. Kyrou

Human Reproduction, 2010

View PDFchevron_right

Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles

Maria Jiménez

Fertility and Sterility, 2008

View PDFchevron_right

Impact of changing the ovarian hyperstimulation protocol in the sequental cycle on ICSI outcomes in the same patient population

Berna Dilbaz

Journal of Gynecology Obstetrics and Human Reproduction, 2021

View PDFchevron_right

Efficacy of low dose hCG on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: a randomized controlled trial

Mohammad Reza akhoond

Journal of Assisted Reproduction and Genetics, 2012

View PDFchevron_right

Adding Low Dose hCG to rFSH in GnRH Antagonist ICSI Cycles: A Randomized Controlled Trial

manal Al-obaidi

Iraqi journal of embryos and infertility researches, 2021

View PDFchevron_right

Clomiphene citrate and hMG: An alternative stimulation protocol for selected failed in vitro fertilization patients

I. Kligman, Claudio Benadiva

Journal of Assisted Reproduction and Genetics, 1995

View PDFchevron_right

The effectiveness of clomiphene citrate in LH surge suppression in women undergoing IUI: a randomized controlled trial

Nada Adel

Fertility and Sterility, 2010

View PDFchevron_right

Repeated Application of Luteal Phase Estradiol / GnRH Antagonist Priming Increases IVF Success for Poor Ovarion Reserve Patients

ULAŞ FİDAN

2022

View PDFchevron_right

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

Esra Aksoy, Halit Erden

Human Reproduction, 2001

View PDFchevron_right

Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy

naima mansouri

Reproductive health, 2015

View PDFchevron_right

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial

Tan Vy

Human Reproduction, 2004

View PDFchevron_right

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study

arianna riva

Fertility and Sterility, 2011

View PDFchevron_right

A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders interv...

S. Sunkara, Peter Braude

Reproductive Health, 2007

View PDFchevron_right

Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?

Raoul Orvieto

Fertility and Sterility, 2008

View PDFchevron_right

Comparison of Two Regimens of Gonadotropin-releasing Hormone Antagonists in Clomiphene-gonadotropin Induced Controlled Ovulation and Intrauterine Insemination Cycles: Randomized Controlled Study

Garima Khadgawat

Journal of human reproductive sciences

View PDFchevron_right

Impact of Two Doses of Agonist Trigger on Assisted Reproductive Technology Outcome

Monna Pandurangi

International Journal of Infertility & Fetal Medicine

View PDFchevron_right